
Chemical and Pharmaceutical Bulletin p. 1505 - 1510 (1995)
Update date:2022-08-04
Topics:
Kuwahara
Kawano
Kawai
Ashida
Miyake
A series of novel ω-substituted alkylthioimidazo[1,2-b]pyridazines was designed and synthesized in an effort to find a novel anti-asthmatic agent. The anti-asthmatic activity of these compounds was evaluated on the basis of their ability to inhibit thromboxane A2 synthetase and platelet activating factor (PAF)-induced bronchoconstriction in guinea pigs. None of these compounds significantly inhibited thromboxane A2 synthetase, though, sulfonamide derivatives potently inhibited PAF-induced bronchoconstriction. Among them, 3-(imidazo[1,2-b]pyridazin-6-yl)thiopropanesulfonamide (5) showed the most potent inhibitory effect. The anti-asthmatic effects of compound 5 in experimental models were superior to those of theophylline.
View Moretaicang liyuan chemical co,.ltd
website:http://www.tcliyuanchem.com/productse.php
Contact:86-512-53539583
Address:Room 804,Huaxu Building,No.95,Renmin South Road,Taicang city,Jiangsu Province,China
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Tianjin Tongde Biological Technology Co., Ltd.
Contact:86-22-23309138
Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
website:http://www.sdowchem.com
Contact:86-135-2193 7483
Address:8-106 taiyue building
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Doi:10.1016/S0040-4039(01)95042-7
(1978)Doi:10.1021/ja00501a030
(1979)Doi:10.1002/adsc.201600425
(2016)Doi:10.1002/ejoc.200500723
(2006)Doi:10.1021/ja048808x
(2004)Doi:10.1021/ja01867a025
(1940)